A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

Lynn Symonds, Isaac Jenkins, Hannah M. Linden, Brenda Kurland, Julie R. Gralow, Vijayakrishna (V K.). Gadi, Georgiana K. Ellis, Qian Wu, Eve Rodler, Pavani Chalasani, Xiaoyu Chai, Jinny Riedel, Network Investigators SCCA Network Investigators, Alison Stopeck, Ursa Brown-Glaberman, Jennifer M. Specht

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences